Liver cancer mortality is declining in men but rising in women. These trends coincide with changes in HCC etiologies along with an increasing contribution of iCCA, particularly in women. Targeted prevention and equitable access to screening are pivotal to reducing mortality.
Fedeli et al. (Wed,) studied this question.